Related Experiment Video
Updated: Jul 1, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Development of effective ocular preparations of antifungal agents
Indu Pal Kaur1, Cheena Rana, Harinder Singh
1University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India. indupalkaur@yahoo.com
Abstract:
In treating ophthalmic mycoses, the ultimate aim is to preserve vision, and this depends on rapid diagnosis and efficient antifungal therapy. Antifungal agents are used both for their superficial action as well as to treat infections of the internal eye. Their clinical efficacy would depend on the concentration achieved in ocular tissue, which, in turn, depends on the molecular mass, route of administration, duration of contact, and ability of the compound to penetrate the eye. Several of these agents have a high molecular mass exceeding 500 Da (such as amphotericin B, natamycin, and ketoconazole), resulting in their poor penetration (even if they are lipophilic in nature). In the present review, we present the physiochemical and pharmacokinetic profile and also the spectrum of antifungal activity of representative antifungal agents recommended for use in treatment of ocular infections. Suitable delivery systems, which can improve the effectiveness of these agents, are suggested as per the nature of each agent. These include liposomes/niosomes, lipid emulsions, nanoparticles including solid lipid nanoparticles, and use of cyclodextrin complexes. The advances made therein, followed by a critical appraisal and suggestions for achieving better therapy as per our expertise, are also included.
Insights
Treating eye fungal infections requires rapid diagnosis and effective antifungal drugs. This review explores drug properties, delivery systems like nanoparticles, and strategies to improve ocular antifungal therapy and preserve vision.
Area of Science:
- Ophthalmology
- Mycology
- Pharmacology
Background:
- Ocular mycoses necessitate prompt diagnosis and effective antifungal treatment to preserve vision.
- Antifungal agents target superficial and internal eye infections, with efficacy dependent on ocular tissue concentration.
- High molecular mass ( > 500 Da) of some antifungals (e.g., amphotericin B, natamycin, ketoconazole) limits ocular penetration.
Purpose of the Study:
- To review the physicochemical, pharmacokinetic, and antifungal activity profiles of key agents for ocular infections.
- To suggest improved delivery systems for enhanced ocular antifungal therapy.
- To critically appraise recent advances and offer expert recommendations for better treatment outcomes.
Main Methods:
- Literature review of antifungal agents used in ophthalmic mycoses.
- Analysis of physiochemical and pharmacokinetic properties influencing ocular drug delivery.
- Evaluation of various drug delivery systems, including liposomes, niosomes, lipid emulsions, nanoparticles, and cyclodextrin complexes.
Main Results:
- Several antifungal agents possess properties that hinder effective ocular penetration.
- Advanced delivery systems show promise in improving the concentration and efficacy of antifungals within ocular tissues.
- Specific delivery strategies are recommended based on the characteristics of individual antifungal agents.
Conclusions:
- Optimizing antifungal drug delivery is crucial for enhancing treatment effectiveness in ophthalmic mycoses.
- Nanoparticles and other advanced systems offer potential solutions to overcome penetration barriers.
- Further research and critical appraisal of therapeutic strategies are needed for improved patient outcomes in treating eye fungal infections.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Antifungal Agents
Antimicrobial Effectiveness
Hand hygiene
Hand washing...
Antiprotozoal Agents
